Cytisine API Manufacturers & Suppliers
Find, compare & contact
Filters
Custom request?
Type
Production region
Qualifications
Country of origin
Engaged in the production of small molecule chemical drug APIs and preparations
Provide CDMO services for high-activity anti-tumor characteristic APIs
153-acre API and preparation production base
+ 0
All certificates
Follow us
Producer
Produced in:
Established in: 1987
MOQ: 1 kg
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 38 years
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Cytisine API 485-35-8?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Cytisine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Cytisine
- Synonyms:
- Baptitoxine , Sophorine , Ulexin
- Cas Number:
- 485-35-8
- DrugBank number:
- DB09028
- Unique Ingredient Identifier:
- 53S5U404NU
About Cytisine
Here, you can find what Cytisine is used for, in short. Cytisine is an alkaloid naturally derived from the Fabaceae family of plants including the genera Laburnum and Cytisus. Recent studies have shown it to be a more effective and significantly more affordable smoking cessation treatment than nicotine replacement therapy. Also known as baptitoxine or sophorine, cytisine has been used as a smoking cessation treatment since 1964, and is relatively unknown in regions outside of central and Eastern Europe.
Cytisine is a partial nicotinic acetylcholine agonist with a half-life of hours. Recent Phase III clinical trials using Tabex (a brand of Cytisine marketed by Sopharma AD) have shown similar efficacy to varenicline, but at a fraction of the cost.
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
Cytisine is a type of Drugs for nicotine addiction
Pharmaceutical APIs (Active Pharmaceutical Ingredients) are crucial components in the development of drugs to combat nicotine addiction. Nicotine addiction is a significant health concern affecting a large population worldwide. To address this issue, pharmaceutical companies focus on developing effective drugs targeting nicotine addiction, utilizing specialized APIs.
These APIs for nicotine addiction drugs play a pivotal role in the formulation of medications that aid in smoking cessation. They act on specific receptors in the brain, modulating the effects of nicotine and reducing cravings. By targeting these receptors, the APIs facilitate the release of neurotransmitters, such as dopamine, which helps to alleviate withdrawal symptoms and reduce the rewarding effects of smoking.
The development of APIs for nicotine addiction drugs requires meticulous research and stringent quality control measures to ensure safety and efficacy. Pharmaceutical companies employ advanced techniques, such as synthetic chemistry and biotechnology, to synthesize these APIs. Rigorous testing and validation are conducted to meet regulatory standards and ensure consistent drug performance.
APIs used in drugs for nicotine addiction are designed to provide a comprehensive approach to smoking cessation. They may be available in various forms, including oral medications, transdermal patches, or inhalers, allowing individuals to choose the most suitable method for their needs.
In conclusion, pharmaceutical APIs for drugs targeting nicotine addiction play a critical role in combating this widespread health issue. By leveraging advanced synthesis techniques and adhering to stringent quality control measures, these APIs form the foundation for effective medications that help individuals overcome nicotine addiction, contributing to improved public health and well-being.
Cytisine (Drugs for nicotine addiction), classified under Anti-addiction agents
Anti-addiction agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment and management of various forms of addiction. These agents target the neurochemical pathways in the brain that are involved in addiction and dependence, offering therapeutic interventions to individuals struggling with substance abuse disorders.
One prominent group of anti-addiction agents includes opioid receptor antagonists, such as naltrexone and naloxone. These APIs bind to opioid receptors in the brain, blocking the euphoric effects of opioids and reducing cravings. By doing so, they help individuals overcome opioid addiction and prevent relapse.
Another essential class of anti-addiction agents are nicotine receptor agonists, like varenicline. These APIs target nicotine receptors in the brain, reducing the pleasurable sensations associated with smoking and alleviating nicotine withdrawal symptoms. This aids in smoking cessation efforts and enhances long-term abstinence rates.
Furthermore, anti-addiction agents may also encompass APIs used in the treatment of alcohol addiction, such as disulfiram and acamprosate. Disulfiram inhibits the breakdown of alcohol in the body, leading to unpleasant reactions when alcohol is consumed, thus discouraging its use. Acamprosate, on the other hand, helps normalize brain activity disrupted by chronic alcohol use, reducing cravings and promoting abstinence.
In conclusion, anti-addiction agents are a critical category of pharmaceutical APIs used to combat addiction and substance abuse disorders. By targeting specific neurochemical pathways, these agents provide valuable support in overcoming addiction, preventing relapse, and improving the overall well-being of individuals affected by substance abuse.
Cytisine manufacturers | traders | suppliers
We have 3 companies offering Cytisine produced in 0 different countries.
Get in contact with the supplier of your choice:
- Sichuan Elixir Pharmaceutical Co., Ltd from China, product country of origin China
- Sinoway industrial Co.,Ltd from China, product country of origin China
- Hunan Bitian Biotechnology Co.,Ltd from China, product country of origin China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
